October 13, 2016
The Federal Circuit on Thursday affirmed a win for the Massachusetts Institute of Technology in its patent infringement suit against Shire Pharmaceuticals Inc. over the drugmaker's Dermagraft treatment for diabetic foot ulcers, saying the district court's claim constructions were correct and that a key term was not indefinite.
January 04, 2013
The Massachusetts Institute of Technology on Friday hit Shire PLC with a patent infringement suit in Massachusetts federal court, alleging that the drugmaker's Dermagraft treatment for diabetic foot ulcers uses a protected method of growing cells to replace damaged skin.